Templates and tutorials

This page contains ready to copy-and-paste section templates that content contributors can use to put together webpages quickly. It also contains various tutorials to address how to perform various operations on the website. 

2. Templates

Hero section

Title Of The Page

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc tincidunt lorem in augue accumsan interdum. Nam nec lacus nulla. Mauris lacinia odio quis auctor vehicula. Mauris tristique ornare sodales. Praesent accumsan pretium erat eu ultrices. Etiam eget egestas mauris. Vivamus blandit imperdiet neque, at cursus magna dignissim 

Page 1
Page 2
Page 3
Page 4

Title Section

Section header

TOPheader

Section Header with background

Subheader description paragraph

TOPHEADER

Section Header without background

Subheader description paragraph

Paragraph with side image

About Kyinno

Preclinical CRO at the Leading Edge of Oncology

Established in 2017, KYinno has collaborated with researchers around the world. We focus on immune therapies and next-generation kinase inhibitor discovery. Our highly skilled scientists have extensive experience in the pharmaceutical and biotechnology industries in the U.S. and China.

About Kyinno

Preclinical CRO at the Leading Edge of Oncology

Established in 2017, KYinno has collaborated with researchers around the world. We focus on immune therapies and next-generation kinase inhibitor discovery. Our highly skilled scientists have extensive experience in the pharmaceutical and biotechnology industries in the U.S. and China.

Cards in a row

Custom Cell Line Construction

About 30 KYinno scientists specialize exclusively in stable cell line generation.

Membrane Proteins Screening Array AB5000

Our simple, efficient, antibody-specific AB5000 platform can achieve early off-target screening.

Common Light Chain Antibody Discovery

Our widely used common light chain cell line products are ready for your studies.

CDX Model

We have developed more than 300 engineered BaF3 cell lines by introducing overexpression or mutation of various kinases.

Common Light Chain Antibody

BsAb: Engineered antibody binding two antigens, activating immune cells, inhibiting tumor signaling. Market: $5.8B in 2023, expecting multi-billion growth by 2030.

Heavy Chain Antibody

Cullinan made an initial payment of $25 million and committed up to $600 million in milestone payments, along with a potential royalty of nearly 20% on sales.

Innopedia Database

Innopedia is a robust database designed to provide researchers with enhanced research tools and data support. The database offers browsing, searching, and analytical capabilities for tumor cell lines, engineered cell lines, and standard antibodies.

Ba/F3 Kinase Cell Lines

Kinases regulate nearly all aspects of cellular activities, and alterations in their expression or gene mutations can lead to the development of cancer and other diseases.

Membrane Proteins Screening Array-AB5000

Antibodies, CAR-T cells, and other biopharmaceuticals rely on the specificity of their target binding, which is a critical factor in assessing the quality of these drugs.

New Resource 1

This is the description of the resource

Product Search and Filters

Filter by Host
Filter by Category
Filter by Generation Method
Filter by Product Type
Catalog
Title
Category
Datasheet